The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections

Antivir Chem Chemother. 2012 Jan 17;22(4):139-50. doi: 10.3851/IMP1873.

Abstract

In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus (RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Biomedical Research
  • Drug Discovery / economics
  • Drug Discovery / methods
  • Drug Industry / economics
  • Humans
  • Models, Biological
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Virus Infections / prevention & control*

Substances

  • Antiviral Agents